Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,263
Closed -$241K 780
2021
Q1
$241K Buy
+5,263
New +$220K 0.02% 673
2020
Q3
Sell
-10,812
Closed -$222K 749
2020
Q2
$222K Buy
+10,812
New +$209K 0.02% 648
2018
Q2
Sell
-4,145
Closed -$207K 796
2018
Q1
$207K Buy
+4,145
New +$209K 0.01% 776
2017
Q4
Sell
-4,445
Closed -$205K 917
2017
Q3
$205K Sell
4,445
-3,242
-42% -$141K 0.01% 833
2017
Q2
$341K Buy
7,687
+2,510
+48% +$105K 0.02% 592
2017
Q1
$213K Buy
+5,177
New +$216K 0.01% 695

Other funds holding SNV

Cigna Investments's SNV Position: Q2 2021 in Review

Cigna Investments sold out of Synovus (SNV) in Q2 2021, closing a stake of 5,263 shares — an estimated $241K sold.

Cigna Investments first reported a position in SNV in Q1 2017 and held it in 6 quarters. The position peaked at $341K in Q2 2017. 378 funds tracked by Wall St. Rank hold SNV as of Q2 2021.

  • Cigna Investments reported no remaining Synovus position as of Q2 2021 after selling out during the quarter.
  • Cigna Investments sold 5,263 Synovus shares in Q2 2021, an estimated $241K.
  • Cigna Investments first reported a position in Synovus in Q1 2017 and held it in 6 quarters.
  • Cigna Investments's Synovus position peaked at $341K in Q2 2017.
  • 378 funds tracked by Wall St. Rank held Synovus as of Q2 2021.

Based on Cigna Investments's 13F filing for Q2 2021, filed 10 Aug 2021.